Drug companies often do one-on-one outreach to doctors. A new study finds these meetings with drug reps lead to more prescriptions for cancer patients, but not longer survival. Chris Hondros/Getty Images hide caption
pharma pharma
Stories About
pharma
Purdue Pharma, maker of the highly addictive OxyContin, is keeping secret the results of an investigation of the Sacklers. Critics want the findings made public. Drew Angerer/Getty Images hide caption
Purdue Pharma Conducted Massive Probe Of The Sacklers, But The Findings Are Secret
Already, Health Canada has posted safety and efficacy data online for four newly approved drugs; it plans to release reports for another 13 drugs and three medical devices approved or rejected since March. Teerapat Seedafong/EyeEm/Getty Images hide caption
Senate Finance Chairman Chuck Grassley, R-Iowa, is joined by Sen. Ron Wyden, D-Ore., the ranking member, at a hearing on the high price of prescription drugs. J. Scott Applewhite/AP hide caption
President Trump listens in January as Stephen Ubl, president and CEO of Pharmaceutical Research and Manufacturers of America (second from left), introduces himself during a meeting at the White House. The sky-high prices of some drugs are a big issue for some voters this fall. Pool/Ron Sachs/Getty Images hide caption
Should TV Drug Ads Be Forced To Include A Price? Trump's Team Says Yes
Despite abuse deterrent formulation, Purdue Pharma's OxyContin continues to be used by some people with opioid addiction to get high. Bloomberg/Bloomberg via Getty Images hide caption